Corporate insider profile
Daniel M Schmitt Insider Trades
Daniel M Schmitt has reported 1 open-market purchase on SEC Form 4 and is a net buyer of $50,000 across 1 company. The most recent open-market transaction was reported on Oct 28, 2026. Source: SEC Form 4 filings.
Latest reported as President, CEO and Director of ACTUATE THERAPEUTICS, INC. (ACTU).
SEC-reported filing activity is provided for research purposes and is not investment advice.
- Purchase filings
- 1
- Reported companies
- 1
- Net open-market value
- $50,000
- Latest transaction
- Oct 28, 2026
Affiliated corporations
Reported company relationships
Transaction history
Open-market Transactions
Common questions
Daniel M Schmitt insider trading FAQ
- Is Daniel M Schmitt buying or selling stock?
- Across all SEC Form 4 open-market filings on record, Daniel M Schmitt is a net buyer of $50,000, with 1 open-market purchase reported. The latest transaction was reported on Oct 28, 2026.
- Which companies does Daniel M Schmitt report insider trades for?
- Daniel M Schmitt has reported open-market trades in ACTUATE THERAPEUTICS, INC. (ACTU). The latest SEC-reported relationship is President, CEO and Director of ACTUATE THERAPEUTICS, INC. (ACTU).
- Where does Daniel M Schmitt's insider trading data come from?
- Watch Insiders reads the SEC Form 4 filings submitted to EDGAR under reporting owner CIK 1318470, and refreshes this page daily.
